Biocon Ltd shares jumped 8.4% on Monday after receiving a ‘Voluntary Action Indicated’ status from the USFDA for its ...

Following the development, the company's share price rose up to 5.69 per cent to hit an intraday high of Rs 339.55 per share on Monday.

Researchers at Tel Aviv University and the Sagol Center for Hyperbaric Medicine and Research at the Shamir Medical Center have demonstrated that hyperbaric oxygen therapy (HBOT) improves the condition ...

Biocon shares surged 5.4% after FDA classified its Bengaluru facility as Voluntary Action Indicated (VAI). The stock is up 47 ...

The rebate game played by drug makers and pharmacy benefit managers limits optimal biosimilar competition. As a result, U.S.

Taking five or more medications daily, known as polypharmacy, is a growing issue for over 30% of older adults. This practice ...

Benchmark restated their hold rating on shares of AbCellera Biologics (NASDAQ:ABCL – Free Report) in a research note published on Tuesday morning,Benzinga reports. ABCL has been the topic of a number ...

Biopharmaceuticals are medicines made from living cells, such as yeast and bacteria, as against conventional drugs that are made from chemicals. They have revolutionised the treatment of chronic ...

The BD Neopak XtraFlow prefillable syringe and Ypsomed YpsoMate auto-injector. [Images courtesy of the companies] BD (NYSE:BDX) and Ypsomed today announced a strategic collaboration to advance ...

Samsung Biologics will use this deal ... The CDMO remains on track to finish the buildout of a dedicated antibody-drug conjugate (ADC) facility by the end of year, and it expects its fifth ...

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

We are now in the era of weight-loss drugs. Decisions on how these drugs will be used look likely to shape our future health and even what our society might look like. And, as researchers are ...